Nepidermin
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Nepidermin
- DrugBank Accession Number
- DB14145
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Beta-urogastrone
- Epidermal growth factor (human)
- Epidermal growth factor biosynthetic human
- Epidermal growth factor human
- H-EGF
- Human EGF
- Human epidermal growth factor
- Human urogastrone
- Nepidermin
- Nepidermina
- Népidermine
- Nepiderminum
- Recombinant human epidermal growth factor
- rhEGF
- Urogastrone
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Burns first degree •••••••••••• Treatment of Burns second degree •••••••••••• Treatment of Diabetic foot ulcers (dfu) •••••••••••• ••••••••• Treatment of Ulcers •••••••••••• ••••••••• Treatment of Wounds •••••••••••• - Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Easyef / Genesoft / Kang He Su / Regen-D
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image EASYDEW DW EGF Derma Needle 3000 Shot Solution 0.000045 mg/45mg Topical Dn Company Co.,Ltd. 2018-03-01 Not applicable US Easydew EX Repair Control Repair Control Egf Liquid 0.0002 g/20mL Topical Dn Company Co.,Ltd. 2018-02-01 Not applicable US EASYDEW EX REPAIR CONTROL REPAIR CONTROL EGF 3mL Liquid 0.03 mg/3mL Topical Dn Company Co.,Ltd. 2018-07-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ARTEMES 3R Effect Hyaluronic Ampoule Nepidermin (0.05 mg/5mL) + Adenosine (0.002 g/5mL) + Nicotinamide (0.10 g/5mL) Liquid Topical Dn Company Co.,Ltd. 2019-03-01 Not applicable US Artemes 3R effect hyaluronic mask Nepidermin (0.33 mg/33g) + Adenosine (0.01 g/33g) + Nicotinamide (0.66 g/33g) Patch Topical Dn Company Co.,Ltd. 2019-03-01 Not applicable US Cosmeceutical Mask Pack Nepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g) Patch Topical YBK Investment, INC 2013-10-21 Not applicable US Cosmeceutical Mask Pack Nepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g) Patch Topical YBK Investment, INC 2013-10-21 2013-10-29 US Dermaheal Cosmeceutical Mask Pack Plus Nepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g) Patch Topical YBK Investment, INC 2013-10-21 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ARTEMES 3R Effect Hyaluronic Ampoule Nepidermin (0.05 mg/5mL) + Adenosine (0.002 g/5mL) + Nicotinamide (0.10 g/5mL) Liquid Topical Dn Company Co.,Ltd. 2019-03-01 Not applicable US Artemes 3R effect hyaluronic mask Nepidermin (0.33 mg/33g) + Adenosine (0.01 g/33g) + Nicotinamide (0.66 g/33g) Patch Topical Dn Company Co.,Ltd. 2019-03-01 Not applicable US Cosmeceutical Mask Pack Nepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g) Patch Topical YBK Investment, INC 2013-10-21 Not applicable US Cosmeceutical Mask Pack Nepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g) Patch Topical YBK Investment, INC 2013-10-21 2013-10-29 US Dermaheal Cosmeceutical Mask Pack Plus Nepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g) Patch Topical YBK Investment, INC 2013-10-21 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- TZK30RF92W
- CAS number
- 62253-63-8
References
- General References
- Not Available
- External Links
- 1427157
- Wikipedia
- Nepidermin
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Active Not Recruiting Treatment Diabetic Foot Ulcers (DFUs) / Epidermal Growth Factor 1 3 Completed Treatment Diabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus 1 3 Unknown Status Treatment Stomatitis 1 2 Completed Prevention Oral Mucositis 1 2 Recruiting Treatment Breast Neoplasms 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Patch Topical Solution Topical 0.000045 mg/45mg Liquid Topical Cream Topical Liquid Topical 0.0002 g/20mL Liquid Topical 0.03 mg/3mL Solution Topical Solution Topical 0.5 mg/ml Spray Topical Solution Intralesional 0.075 mg Injection, powder, lyophilized, for solution Intralesional 75 mcg Lotion Topical Gel Topical 150 mcg/g Gel Topical Powder 0.075 mg/1vial - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at June 27, 2018 20:17 / Updated at May 04, 2022 16:30